Dangerous Drugs and Medical Devices
December 28, 2011
Tremont Sheldon Robinson Mahoney is looking into claims against drug companies and medical device manufacturers that are producing drugs and devices that have serious side effects or can even cause death. With our extensive background in medical malpractice, our attorneys are advising clients on lawsuits related to defective medical products, surgical equipment, and/or medication. We are looking into the following products/medications:
Fosamax is the most popular osteoporosis drug on the market, but recent studies have uncovered a defect in the medication. Many who have taken Fosamax are suffering low-impact femur fractures—breaks of the thigh bone that occur due to falls from standing height or less. It turned out that rather than strengthen bones, Fosamax causes them to become brittle and to break under modest stress. Two studies have shed light on the atypical femur fractures.
Yaz/Yasmin/Ocella (generic name)
These birth control drugs have side effects, which can result in a multitude of health problems from heart attacks to strokes, gallbladder disease and blood clots. Blood clots including pulmonary embolism, DVT, and stroke have been associated with the use of this relatively new birth control pill. Further, the medication has caused such damage to the gallbladder
that it has required gallbladder removal surgery. (Gallbladder disease includes inflammation, infection, stones, or obstructions of the gallbladder.) According to the Food and Drug Administration (FDA), “between the first quarter of 2004 and the third quarter of 2008, 50 women and girls who took Yaz in the United States died from medical complications.” Women who have been on Yaz/Yasmin or the generic version Ocella have a greater risk of developing future blood clots and a lifetime of being on blood thinners. By coming forward, women who have been affected by Yaz help create more awareness of the problems with some of the newer combination hormone birth control.
– It has increasingly been reported that this drug, which is prescribed to treat diabetes, has been linked to an increased risk of developing bladder cancer. In June 2011 the Food and Drug Administration (FDA) announced that patients using the diabetes medicine Actos (generic name – pioglitazone) for longer than a year may be linked with an elevated risk for developing bladder cancer. The FDA found that the longer patients took drugs containing pioglitazone, like Actos, the greater the risk of developing bladder cancer. The same Actos bladder cancer connection was also found in patients with the highest cumulative dose of the drug.
DePuy Hip System
DePuy Orthopaedics has recalled its ASR replacement hip system because its components can come loose, fracturing the bone around the implant, depositing metal fragments in the bloodstream and causing pseudotumors. The DePuy ASR™ XL Acetabular Hip System and DePuy ASR™ Hip Resurfacing System have a 12 to 13 percent chance of failing within five years. Upon failure, a patient may experience some or all of the following: pseudotumors, increased levels of chromium in the blood, loosening or dislocation of the implant, hip bone fracture, and/or an inflamed joint that can complicate corrective surgery. Over 93,000 United States patients received this faulty system.
If you think that you have been a victim of any of these dangerous drugs or faulty medical devices, contact your doctor immediately to ensure your proper medical care. In addition, if you believe that faulty medical products or prescription drugs may have caused you pain or suffering, we want to hear from you. Please call Jason Tremont at 203-212-9075.